Favezelimab [2231068-83-8]

TargetMol Chemicals

Favezelimab

9

2231068-83-8

Antibody

Research Use Only

Favezelimab

Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that inhibits the LAG-3/MHC class II interaction and shows potential for use in colorectal cancer (CRC) research, particularly when combined with the PD-L1 inhibitor pembrolizumab [1][2].

3 years

-20°C

12352203